Zhijian Xiao

22PUBLICATIONS
27CO-AUTHORS
Haematological tumoursEpidemiological methodsMolecular targetsSoftware quality, processes and metricsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 15, 2026
Clinical Characteristics of Coexistent Chronic Myeloid Leukemia and BCR::ABL1 Negative Myeloproliferative Neoplasms: A Retrospective Study.

|Sep 29, 2026
Exposure-Response Analyses of Ropeginterferon Alfa-2b in Essential Thrombocythemia.

|Jul 29, 2026
Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy.

|Jun 18, 2026
Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 Mutation.

|Dec 18, 2024
Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study.

Yi Zhang, Hu Zhou, Shanshan Suo

|May 07, 2024
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis.

Fuhui Li, Tiejun Qin, Bing Li

Pageof 4

Frequent Collaborators

4 joint publications

Zefeng Xu

3 joint publications

Wenyu Cai

3 joint publications

Bing Li

3 joint publications

Robert Peter Gale